Article

Countdown to a possible new drug approval for kidney cancer

Author(s):

Melissa Weber

Just got word from a Genentech spokesperson that the company expects to hear by the end of this week whether the FDA will approve Avastin for metastatic kidney cancer. (Check out the kidney cancer feature in our current issue.)We'll keep you posted.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of man with text.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how unprepared she felt despite good guidance.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Related Content
Image of kidney.
July 19th 2025

Personalized Neoantigen Vaccines Show Lasting Tumor Control in Kidney Cancer

Ashling Wahner
Early data suggest personalized neoantigen vaccines activate the immune system and sustain tumor control in some patients with kidney cancer.
The Importance of Spotting Endometrial Cancer
March 18th 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Image of woman.
July 18th 2025

What Makes a Quality Cancer Support Group?

Sue McCarthy
After attending several cancer support groups, I reflect on what makes them helpful, inclusive and healing — and invite others to share their insights too.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Jane Biehl is a 12-year survivor of a very rare form of blood cancer, known as myelodysplastic syndrome (MDS). Catch up on all of Jane’s blogs here!
July 18th 2025

Max The Butterfly: Hope and Resurrection After Cancer

Jane Biehl Ph.D.
Butterflies are believed to be a symbol of resurrection and hope. This is an inspiring story about this phenomenon.
Image of FDA sign.
July 18th 2025

FDA Votes Against Proposed Blenrep Treatment Combo’s for Multiple Myeloma

Ryan Scott
The FDA's Oncologic Drugs Advisory Committee has casted their votes on the utilization of certain treatments in the multiple myeloma patient population.